Aromatherapy With Lavender Essential Oil in Patients With Multiple Sclerosis
Aromatherapy, Randomized Controlled Trial, Multiple Sclerosis
About this trial
This is an interventional supportive care trial for Aromatherapy
Eligibility Criteria
Inclusion Criteria: Being 18 years or older, Having been diagnosed with MS at least 1 year ago, Verbal communication (hearing and speaking) No problem with sense of smell, Not having an allergy to lavender, Having fatigue and sleep problems for the last 3 months, Not applying an intervention that helps to fall asleep, Pittsburgh Sleep Quality Index ≥5, Fatigue Severity Scale ≥4. Exclusion Criteria: Having had an attack in the last month, Having DSM-IV Axis I disorder, Pregnancy, Using sleeping pills, Breastfeeding
Sites / Locations
- Ataturk Unıversity
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Experimental
Control
Lavender oil in 15 ml opaque dark colored bottles closed with metal caps to prevent volatility to the venture group and 40 2×2 cotton pads were delivered. Patients were asked to apply lavender oil 30 minutes before going to bed. Deep breathing increases the concentration of aromatic substances in the body. The time it takes for essential oils to be absorbed into the blood circulatory system is about 30 minutes for complete absorption by the body. Information was given about dripping 3 drops of lavender oil on cotton pads and placing them 15-20 cm away from the pillow. Patients were told that they should apply lavender oil for 30 days and re-prepare the lavender oil dripped onto a new pad each night, and that the bedroom should be ventilated and free of different odors. A message was sent to the patients to remind them of the application on their phones for 30 days.
No intervention will be applied to the control group.